Cargando…

Phytochemicals as potential drug candidates for targeting SARS CoV 2 proteins, an in silico study

Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) is a member of the family Coronaviridae, and the world is currently witnessing a global pandemic outbreak of this viral disease called COVID-19. With no specific treatment regime, this disease is now a serious threat to humanity and claimi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nag, Anish, Banerjee, Ritesh, Chowdhury, Rajshree Roy, Krishnapura Venkatesh, Chandana
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer India 2021
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8020371/ https://www.ncbi.nlm.nih.gov/pubmed/33842673 http://dx.doi.org/10.1007/s13337-021-00654-x

Ejemplares similares

In silico study of some selective phytochemicals against a hypothetical SARS-CoV-2 spike RBD using molecular docking tools
por: Nag, Anish, et al.
Publicado: (2021)

Curcumin inhibits spike protein of new SARS-CoV-2 variant of concern (VOC) Omicron, an in silico study
por: Nag, Anish, et al.
Publicado: (2022)

In-silico approach to designing effective antiviral drugs against SARS-CoV-2 and SARS-CoV-1 from reported phytochemicals: a quality improvement study
por: Tuz-Zohura, Fatema-, et al.
Publicado: (2023)

In silico analysis of Phyllanthus amarus phytochemicals as potent drugs against SARS-CoV-2 main protease
por: Murthy, T.P. Krishna, et al.
Publicado: (2021)

In-silico screening of naturally derived phytochemicals against SARS-CoV Main protease
por: Mostafa, Islam, et al.
Publicado: (2021)

Evaluation of therapeutic potentials of selected phytochemicals against Nipah virus, a multi-dimensional in silico study
por: Rababi, Deblina, et al.
Publicado: (2023)

In silico exploration of binding potentials of anti SARS-CoV-1 phytochemicals against main protease of SARS-CoV-2
por: Al-Sehemi, Abdullah G., et al.
Publicado: (2022)

Phytochemicals against SARS-CoV as potential drug leads
por: Swain, Shasank Sekhar, et al.
Publicado: (2021)

A SARS-CoV-2 vaccine candidate: In-silico cloning and validation
por: Bhattacharya, Manojit, et al.
Publicado: (2020)

Drug Repurposing for Candidate SARS-CoV-2 Main Protease Inhibitors by a Novel In Silico Method
por: Sencanski, Milan, et al.
Publicado: (2020)

In Silico Analysis of the Apoptotic and HPV Inhibitory Roles of Some Selected Phytochemicals Detected from the Rhizomes of Greater Cardamom
por: Nag, Anish, et al.
Publicado: (2022)

Plant Metabolites as SARS-CoV-2 Inhibitors Candidates: In Silico and In Vitro Studies
por: Lopes, Alberto Jorge Oliveira, et al.
Publicado: (2022)

Exploring the Drug Potential of Phytochemicals as a Novel Therapeutic Drug Candidate for Herpesvirus: An In-silico Evaluation
por: Rani, A. Christy, et al.
Publicado: (2022)

Assessing the Potential Contribution of In Silico Studies in Discovering Drug Candidates That Interact with Various SARS-CoV-2 Receptors
por: Mushebenge, Aganze Gloire-Aimé, et al.
Publicado: (2023)

Solanaceae Family Phytochemicals as Inhibitors of 3C-Like Protease of SARS-CoV-2: An In Silico Analysis
por: Mahmood, Raisul Awal, et al.
Publicado: (2022)

In Silico and In Vivo Evaluation of SARS-CoV-2 Predicted Epitopes-Based Candidate Vaccine
por: Shehata, Mahmoud M., et al.
Publicado: (2021)

In Silico Evaluation of Prospective Anti-COVID-19 Drug Candidates as Potential SARS-CoV-2 Main Protease Inhibitors
por: Ibrahim, Mahmoud A. A., et al.
Publicado: (2021)

Unravelling lead antiviral phytochemicals for the inhibition of SARS-CoV-2 M(pro) enzyme through in silico approach
por: Gurung, Arun Bahadur, et al.
Publicado: (2020)

Exploring the pharmacological aspects of natural phytochemicals against SARS-CoV-2 Nsp14 through an in silico approach
por: De, Arkajit, et al.
Publicado: (2023)

In silico screening, ADMET analysis and MD simulations of phytochemicals of Onosma bracteata Wall. as SARS CoV-2 inhibitors
por: Vegad, Udaykumar G., et al.
Publicado: (2023)

Impact of B.1.617 and RBD SARS-CoV-2 variants on vaccine efficacy: An in-silico approach
por: Ranjan, Prashant, et al.
Publicado: (2022)

Evaluation of tea (Camellia sinensis L.) phytochemicals as multi-disease modulators, a multidimensional in silico strategy with the combinations of network pharmacology, pharmacophore analysis, statistics and molecular docking
por: Nag, Anish, et al.
Publicado: (2022)

Candidate drugs against SARS-CoV-2 and COVID-19
por: McKee, Dwight L., et al.
Publicado: (2020)

An in-silico pharmacophore-based molecular docking study to evaluate the inhibitory potentials of novel fungal triterpenoid Astrakurkurone analogues against a hypothetical mutated main protease of SARS-CoV-2 virus
por: Nag, Anish, et al.
Publicado: (2023)

Indian Ethnomedicinal Phytochemicals as Promising Inhibitors of RNA-Binding Domain of SARS-CoV-2 Nucleocapsid Phosphoprotein: An In Silico Study
por: Muthumanickam, Sankar, et al.
Publicado: (2021)

In silico studies of anti-oxidative and hot temperament-based phytochemicals as natural inhibitors of SARS-CoV-2 M(pro)
por: Naderi Beni, Ramin, et al.
Publicado: (2023)

Computational and comparative investigation of hydrophobic profile of spike protein of SARS-CoV-2 and SARS-CoV
por: Shekhawat, Uma, et al.
Publicado: (2022)

Design an Efficient Multi-Epitope Peptide Vaccine Candidate Against SARS-CoV-2: An in silico Analysis
por: Yazdani, Zahra, et al.
Publicado: (2020)

Understanding the role of galectin inhibitors as potential candidates for SARS-CoV-2 spike protein: in silico studies
por: Sethi, Aaftaab, et al.
Publicado: (2020)

Evolving geographic diversity in SARS-CoV2 and in silico analysis of replicating enzyme 3CL(pro) targeting repurposed drug candidates
por: Chitranshi, Nitin, et al.
Publicado: (2020)

In silico study of novel niclosamide derivatives, SARS-CoV-2 nonstructural proteins catalytic residue-targeting small molecules drug candidates
por: Lawal, Bashir, et al.
Publicado: (2023)

Antivirals Against Coronaviruses: Candidate Drugs for SARS-CoV-2 Treatment?
por: Santos, Igor de Andrade, et al.
Publicado: (2020)

Indole-Based Compounds as Potential Drug Candidates for SARS-CoV-2
por: Girgis, Adel S., et al.
Publicado: (2023)

In silico investigation of ACE2 and the main protease of SARS-CoV-2 with phytochemicals from Myristica fragrans (Houtt.) for the discovery of a novel COVID-19 drug
por: Ongtanasup, Tassanee, et al.
Publicado: (2022)

In silico validation of potent phytochemical orientin as inhibitor of SARS-CoV-2 spike and host cell receptor GRP78 binding
por: Bhowmik, Arijit, et al.
Publicado: (2021)

Potential combination therapy using twenty phytochemicals from twenty plants to prevent SARS- CoV-2 infection: An in silico Approach
por: Dey, Dipjyoti, et al.
Publicado: (2021)

Identification of SARS-CoV-2 RNA-dependent RNA polymerase inhibitors from the major phytochemicals of Nigella sativa: An in silico approach
por: Mir, Shabir Ahmad, et al.
Publicado: (2022)

In Silico Drug Repurposing for SARS-CoV-2 Main Proteinase and Spike Proteins
por: Maffucci, Irene, et al.
Publicado: (2020)

An ayurvedic perspective along with in silico study of the drugs for the management of SARS-CoV-2
por: Gandhi, Abhay Jayprakash, et al.
Publicado: (2022)

In silico analysis of SARS-CoV-2 proteins as targets for clinically available drugs
por: Chan, Wallace K. B., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_sm0jojmqivr7kdrhrljotfijqm